143 related articles for article (PubMed ID: 38627543)
21. Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
Frey MK; Ahsan MD; Bergeron H; Lin J; Li X; Fowlkes RK; Narayan P; Nitecki R; Rauh-Hain JA; Moss HA; Baltich Nelson B; Thomas C; Christos PJ; Hamilton JG; Chapman-Davis E; Cantillo E; Holcomb K; Kurian AW; Lipkin S; Offit K; Sharaf RN
J Clin Oncol; 2022 Dec; 40(35):4129-4143. PubMed ID: 35960887
[TBL] [Abstract][Full Text] [Related]
22. Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.
Bednar EM; Rauh-Hain JA; Garcia JJ; de Aguinaga N; Powell MA; Peral SL; Nitecki R; Jorgensen K; Rudy NL; Lu KH; Leath CA; Scarinci IC
Cancer Prev Res (Phila); 2024 Jan; 17(1):19-28. PubMed ID: 37913800
[TBL] [Abstract][Full Text] [Related]
23. Process and outcome in communication of genetic information within families: a systematic review.
Gaff CL; Clarke AJ; Atkinson P; Sivell S; Elwyn G; Iredale R; Thornton H; Dundon J; Shaw C; Edwards A
Eur J Hum Genet; 2007 Oct; 15(10):999-1011. PubMed ID: 17609674
[TBL] [Abstract][Full Text] [Related]
24. A general approach to genetic counseling.
Plunkett KS; Simpson JL
Obstet Gynecol Clin North Am; 2002 Jun; 29(2):265-76. PubMed ID: 12108827
[TBL] [Abstract][Full Text] [Related]
25. Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication.
Pollard S; Kalloger S; Weymann D; Sun S; Nuk J; Schrader KA; Regier DA
Health Expect; 2020 Aug; 23(4):884-892. PubMed ID: 32338425
[TBL] [Abstract][Full Text] [Related]
26. A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives.
Vos J; Menko F; Jansen AM; van Asperen CJ; Stiggelbout AM; Tibben A
Fam Cancer; 2011 Mar; 10(1):87-96. PubMed ID: 20852944
[TBL] [Abstract][Full Text] [Related]
27. Genetic Testing and Counseling for Hypertrophic Cardiomyopathy.
Cirino AL; Seidman CE; Ho CY
Cardiol Clin; 2019 Feb; 37(1):35-43. PubMed ID: 30447714
[TBL] [Abstract][Full Text] [Related]
28. Genetic testing for disease susceptibilities: consequences for genetic counseling.
Pagon RA
Trends Mol Med; 2002 Jun; 8(6):306-7. PubMed ID: 12067618
[TBL] [Abstract][Full Text] [Related]
29. Genetic testing for von Willebrand disease: the case against.
Favaloro EJ
J Thromb Haemost; 2010 Jan; 8(1):6-12. PubMed ID: 19453940
[No Abstract] [Full Text] [Related]
30. Communication of genetic information to at-risk relatives during the multidisciplinary monitoring of vascular Ehlers-Danlos syndrome in a French referral clinic.
Mazzella JM; Adham S; Frank M; Legrand A; Lahlou-Laforêt K; Jeunemaitre X
J Genet Couns; 2020 Oct; 29(5):828-837. PubMed ID: 31903687
[TBL] [Abstract][Full Text] [Related]
31. An agenda for personalized medicine.
Ng PC; Murray SS; Levy S; Venter JC
Nature; 2009 Oct; 461(7265):724-6. PubMed ID: 19812653
[No Abstract] [Full Text] [Related]
32. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
[TBL] [Abstract][Full Text] [Related]
33. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
[TBL] [Abstract][Full Text] [Related]
34. Communication Between Breast Cancer Patients Who Received Inconclusive Genetic Test Results and Their Daughters and Sisters Years After Testing.
Baars JE; Ausems MG; van Riel E; Kars MC; Bleiker EM
J Genet Couns; 2016 Jun; 25(3):461-71. PubMed ID: 26446011
[TBL] [Abstract][Full Text] [Related]
35. The ethics of direct-to-consumer genetic testing.
Udesky L
Lancet; 2010 Oct; 376(9750):1377-8. PubMed ID: 20979325
[No Abstract] [Full Text] [Related]
36. Direct-to-consumer genetic testing: access and marketing.
McCabe LL; McCabe ER
Genet Med; 2004; 6(1):58-9. PubMed ID: 14726811
[No Abstract] [Full Text] [Related]
37. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
[TBL] [Abstract][Full Text] [Related]
38. [When to refer patients for oncogenetic counseling?].
Viassolo V; Chappuis PO
Rev Med Suisse; 2016 May; 12(519):966, 968-72. PubMed ID: 27424422
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Personal Utility of Genetic Risk Testing.
David SP; Palaniappan L
Am Fam Physician; 2018 May; 97(9):600-602. PubMed ID: 29763257
[No Abstract] [Full Text] [Related]
40. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.
van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M
Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
